Mitsui Global Investment

Type

CVC

Status

Active

Location

Menlo Park, United States

Total investments

148

Average round size

20M

Portfolio companies

111

Rounds per year

6.43

Lead investments

14

Follow on index

0.24

Exits

49

Stages of investment
Early Stage VentureLate Stage Venture
Areas of investment
BiotechnologyInternetSoftwareInformation TechnologyMobileHealth CareManufacturingSecurityMedicalWireless

Summary

In 2001 was created Mitsui Global Investment, which is appeared as VC. The fund was located in North America if to be more exact in United States. Mitsui Global Investment seemed to be an CVC arrangement as part of the organization. The leading representative office of defined VC is situated in the Menlo Park.

The important activity for fund was in 2012. Despite it in 2019 the fund had an activity. Comparing to the other companies, this Mitsui Global Investment performs on 1 percentage points more the average number of lead investments. The higher amount of exits for fund were in 2014. Considering the real fund results, this VC is 7 percentage points less often commits exit comparing to other organizations. The fund is constantly included in 7-12 investment rounds annually. The common things for fund are deals in the range of 10 - 50 millions dollars.

The fund has exact preference in a number of founders of portfolio startups. In case when startup counts 5+ of the founder, the chance for it to get the investment is meager. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. We can highlight the next thriving fund investment areas, such as Biotechnology, Electronics. Moreover, a startup needs to be at the age of 4-5 years to get the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight iSoftStone, Change Healthcare, Change Healthcare.

The overall number of key employees were 11.

The standard case for the fund is to invest in rounds with 5-6 partakers. Despite the Mitsui Global Investment, startups are often financed by Goldman Sachs, Intel Capital, Sequoia Capital. The meaningful sponsors for the fund in investment in the same round are Kleiner Perkins, Goldman Sachs, Samsung Ventures. In the next rounds fund is usually obtained by Silicon Valley Bank, Kleiner Perkins, Goldman Sachs.

Show more

Investor highlights

Industry focus
Biotech/Life SciencesHealthcareAgricultureFoodtechFintech Show 1 more
Stage focus
Seed
Geo focus
Generalist

Discover reliable insights

Find relevant VC investors, identify key contacts and secure funding opportunities.

Investments analytics

Analytics

Total investments
148
Lead investments
14
Exits
49
Rounds per year
6.43
Follow on index
0.24
Investments by industry
  • Biotechnology (38)
  • Health Care (28)
  • Software (24)
  • Medical (18)
  • Manufacturing (17)
  • Show 156 more
Investments by region
  • United States (107)
  • Canada (4)
  • Israel (6)
  • China (11)
  • Singapore (2)
  • Show 7 more
Peak activity year
2012
Number of Decacorns
1
Number of Minotaurs
1

Discover reliable insights

Leverage validated data, identify key contacts and secure funding opportunities for your business.

Quantitative data

Avg. startup age at the time of investment
17
Avg. valuation at time of investment
171M
Group Appearance index
0.91
Avg. company exit year
11
Avg. multiplicator
6.15
Strategy success index
0.70

Need more data?

Get access to full data about investors, including their team, contact information, and historic data.

Latest deals

Company name Deal date Industry Deal stage Deal size Location
Change Healthcare 17 Jan 2012 Information Technology, Health Care, Medical, Home Health Care Late Stage Venture 9M United States, Nashville, Tennessee
Reunion Neuroscience 02 May 2024 Biotechnology, Pharmaceutical Early Stage Venture 103M Ontario, Toronto, Canada
How we get our data

At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).

Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.